Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

Recruiting now

Conditions studied: Liver Transplant, Hepatitis C, Chronic Kidney Disease, Acute Rejection

In brief

This study is being done to test blood, urine and tissue samples to see if this can help decide if CKD (Chronic Kidney Disease), AR (Acute Rejection) and HCV (Hepatitis C Virus) can be identified in its early stages. CKD damage to the kidneys, AR and HCV all lower the body's ability to function properly. Early detection of these conditions could assist with successful treatment and possibly lead to less repeat organ transplants.

Key facts

Study ID

NCT01644903

Run by

Northwestern University

People needed

1000

Starts

2010-04-01

Expected to finish

2031-12-01

Last updated by the study team

2026-05-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female recipients of all races, ≥18 years of age.
• Patients undergoing primary or subsequent living or deceased donor liver transplantation.
• Subject and/or guardian must be able to provide informed consent.
• Subject and/or guardian must be able to comply with the study protocol.

You may not qualify if…

• Inability or unwillingness of a participant and/or guardian to provide informed consent.

Where it is running

• Northwestern Memorial Hospital — Chicago, Illinois, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.